Unraveling Intricate Hypoxia Signaling Networks and Implications for Cancer Development and Therapy

Hypoxia is a long-lasting physiological characteristic of several solid tumors and a primary factor contributing to malignancy. In recent times, it has been acknowledged as a significant focus for cancer treatment. Hypoxia is a common occurrence in most solid tumors because the blood vessels supplying oxygen are inadequate to fulfill the demands of rapidly dividing cancer cells. A tumor microenvironment (TME) that lacks oxygen can diminish the efficacy of various tumor treatments, including radiation, chemotherapy, and immunotherapy. This review examines the crucial significance of hypoxia in the process of tumor formation, encompassing tumor metabolism, tumor immunology, and tumor angiogenesis. The therapeutic strategies for hypoxic TME can be categorized into hypoxia-targeted therapy and interventions aimed at ameliorating tumor hypoxia to enhance oxygenation. Hyperoxia therapy can be employed to enhance the oxygen levels in tissues and alleviate the condition of low oxygen levels in tumors, known as tumor hypoxia. Hypoxia is a powerful environmental element that enhances the spread of tumors. Recent studies have discovered how hypoxia and the activation of hypoxia-inducible factor (HIF)-dependent signaling contribute to the spread of cancer through various mechanisms. These mechanisms include the regulation of metabolic reprogramming, the development of a stem cell-like phenotype, invasion of surrounding tissues, formation of new blood vessels (angiogenesis), suppression of the immune system, preparation of a favorable environment for metastasis (premetastatic niche), entry into and exit from blood vessels (intra/extravasation), and resistance to cell death (apoptosis). These findings propose innovative models in the spread of cancer to other parts of the body and reveal new possibilities for medical intervention in the prevention and treatment of cancer. In this chapter, we will go over the basic principles of hyperoxia signaling, how they affect the present and future of cancer treatment, and the implications of hyperoxia therapy for cancer development.